Donate

Tag: FDA

Consumer Gene Tests Face Uncertain Future

KQED Science | May 5, 2014 | 1 Comment

Consumer Gene Tests Face Uncertain Future

Personal genetics companies that offer health insights are working to satisfy federal regulators and keep up with changing science.

Continue Reading

Click to “Like” My Genome: Part Two

KQED Science | December 17, 2013 | 1 Comment

Click to “Like” My Genome: Part Two

The FDA challenge may hurt the personal genetics industry in the short run. No traits, no health risks -- no fun. But the company is still allowed to show ancestry results. 23andMe's map of my distant relations offered a glimpse of the movement of people across the world. The more people who joined and shared their genomes, the more comprehensive a picture we could form of a global family tree. A day might come when I would know precisely how related I was to, for example -- you.

Continue Reading

Consumer Genetic Testing Company 23andMe Faces Its Own Test From the FDA

KQED Science | December 9, 2013 | 1 Comment

Consumer Genetic Testing Company 23andMe Faces Its Own Test From the FDA

In response to a letter from the FDA, a direct-to-consumer (DTC) genetic testing company in Mountain View, California called 23andMe has agreed to stop providing health data on new purchases of its $99 genetic tests.

Continue Reading